1. The Advantage Plus Pass-Thru AER is a disinfection system for commonly used endoscopes.
2. The Bruker MALDI Biotyper CA system may now be used to identify the emerging pathogen Candida auris.
3. Crysvita is the first drug approved to treat x-linked hypophosphatemia — a rare, inherited form of rickets.
4. Tagrisso may now be used as a first-line treatment for patients with metastatic non-small cell lung cancer with a specific genetic mutation.
More articles on supply chain:
‘Convoluted’ and ‘expensive’ among US employers’ most common descriptors for the drug supply chain
Mylan eliminates more than 400 positions at West Virginia plant: 3 notes
Safety violations at PharMEDium worsen hospital painkiller shortage
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
